480 related articles for article (PubMed ID: 15218994)
1. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD.
O'Donnell DE; Flüge T; Gerken F; Hamilton A; Webb K; Aguilaniu B; Make B; Magnussen H
Eur Respir J; 2004 Jun; 23(6):832-40. PubMed ID: 15218994
[TBL] [Abstract][Full Text] [Related]
2. Tiotropium and exercise training in COPD patients: effects on dyspnea and exercise tolerance.
Ambrosino N; Foglio K; Balzano G; Paggiaro PL; Lessi P; Kesten S;
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):771-80. PubMed ID: 19281092
[TBL] [Abstract][Full Text] [Related]
3. Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.
Beeh KM; Singh D; Di Scala L; Drollmann A
Int J Chron Obstruct Pulmon Dis; 2012; 7():503-13. PubMed ID: 22973092
[TBL] [Abstract][Full Text] [Related]
4. Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
Celli B; ZuWallack R; Wang S; Kesten S
Chest; 2003 Nov; 124(5):1743-8. PubMed ID: 14605043
[TBL] [Abstract][Full Text] [Related]
5. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD.
Maltais F; Hamilton A; Marciniuk D; Hernandez P; Sciurba FC; Richter K; Kesten S; O'Donnell D
Chest; 2005 Sep; 128(3):1168-78. PubMed ID: 16162703
[TBL] [Abstract][Full Text] [Related]
6. Effect of QVA149 on lung volumes and exercise tolerance in COPD patients: the BRIGHT study.
Beeh KM; Korn S; Beier J; Jadayel D; Henley M; D'Andrea P; Banerji D
Respir Med; 2014 Apr; 108(4):584-92. PubMed ID: 24534204
[TBL] [Abstract][Full Text] [Related]
7. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
Diba C; King GG; Berend N; Salome CM
Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
[TBL] [Abstract][Full Text] [Related]
8. Effects of tiotropium on sympathetic activation during exercise in stable chronic obstructive pulmonary disease patients.
Yoshimura K; Maekura R; Hiraga T; Kitada S; Miki K; Miki M; Tateishi Y
Int J Chron Obstruct Pulmon Dis; 2012; 7():109-17. PubMed ID: 22615527
[TBL] [Abstract][Full Text] [Related]
9. Effects of tiotropium on hyperinflation and treadmill exercise tolerance in mild to moderate chronic obstructive pulmonary disease.
Casaburi R; Maltais F; Porszasz J; Albers F; Deng Q; Iqbal A; Paden HA; O'Donnell DE;
Ann Am Thorac Soc; 2014 Nov; 11(9):1351-61. PubMed ID: 25289942
[TBL] [Abstract][Full Text] [Related]
10. Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD.
Casaburi R; Kukafka D; Cooper CB; Witek TJ; Kesten S
Chest; 2005 Mar; 127(3):809-17. PubMed ID: 15764761
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of dyspnoea relief and improved exercise endurance after furosemide inhalation in COPD.
Jensen D; Amjadi K; Harris-McAllister V; Webb KA; O'Donnell DE
Thorax; 2008 Jul; 63(7):606-13. PubMed ID: 18250181
[TBL] [Abstract][Full Text] [Related]
12. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD.
O'Donnell DE; Hamilton AL; Webb KA
J Appl Physiol (1985); 2006 Oct; 101(4):1025-35. PubMed ID: 16675610
[TBL] [Abstract][Full Text] [Related]
13. Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.
Berton DC; Reis M; Siqueira AC; Barroco AC; Takara LS; Bravo DM; Andreoni S; Neder JA
Respir Med; 2010 Sep; 104(9):1288-96. PubMed ID: 20580216
[TBL] [Abstract][Full Text] [Related]
14. Effects of combined tiotropium/olodaterol on inspiratory capacity and exercise endurance in COPD.
O'Donnell DE; Casaburi R; Frith P; Kirsten A; De Sousa D; Hamilton A; Xue W; Maltais F
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28424359
[TBL] [Abstract][Full Text] [Related]
15. The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function.
Cooper CB
Am J Med; 2006 Oct; 119(10 Suppl 1):21-31. PubMed ID: 16996896
[TBL] [Abstract][Full Text] [Related]
16. The effect of tiotropium on hyperinflation and exercise capacity in chronic obstructive pulmonary disease.
Verkindre C; Bart F; Aguilaniu B; Fortin F; Guérin JC; Le Merre C; Iacono P; Huchon G
Respiration; 2006; 73(4):420-7. PubMed ID: 16484769
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic steady state of tiotropium in patients with chronic obstructive pulmonary disease.
van Noord JA; Smeets JJ; Custers FL; Korducki L; Cornelissen PJ
Eur Respir J; 2002 Apr; 19(4):639-44. PubMed ID: 11998992
[TBL] [Abstract][Full Text] [Related]
18. Effect of 12 weeks of once-daily tiotropium/olodaterol on exercise endurance during constant work-rate cycling and endurance shuttle walking in chronic obstructive pulmonary disease.
Maltais F; O'Donnell D; Gáldiz Iturri JB; Kirsten AM; Singh D; Hamilton A; Tetzlaff K; Zhao Y; Casaburi R
Ther Adv Respir Dis; 2018; 12():1753465818755091. PubMed ID: 29439648
[TBL] [Abstract][Full Text] [Related]
19. Effect of tiotropium on neural respiratory drive during exercise in severe COPD.
Qin YY; Li RF; Wu GF; Zhu Z; Liu J; Zhou CZ; Guan WJ; Luo JY; Yu XX; Ou YM; Jiang M; Zhong NS; Luo YM
Pulm Pharmacol Ther; 2015 Feb; 30():51-6. PubMed ID: 25449059
[TBL] [Abstract][Full Text] [Related]
20. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group.
Casaburi R; Briggs DD; Donohue JF; Serby CW; Menjoge SS; Witek TJ
Chest; 2000 Nov; 118(5):1294-302. PubMed ID: 11083677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
